Reviva Pharmaceuticals Holdings, Inc.RVPHNASDAQ
Loading
EPS Growth AcceleratingAccelerating
Percentile Rank83
3Y CAGR-5.1%
Studio
Year-over-Year Change

Year-over-year earnings per share growth rate

3Y CAGR
-5.1%/yr
Annual compound
Percentile
P83
Within normal range
vs 3Y Ago
0.9x
Contraction
Streak
2 yr
Consecutive growthAccelerating
PeriodValue
202445.45%
2023-13.79%
2022-150.00%
202153.23%
2020-300.00%
2019-210.12%
20180.00%